Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E- EPS (ttm)-14.28 Insider Own0.65% Shs Outstand0.72M Perf Week-0.32%
Market Cap0.54M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.17M Perf Month-27.19%
Income-7.91M PEG- EPS next Q- Inst Own120.32% Short Float19.45% Perf Quarter-37.30%
Sales4.83M P/S0.11 EPS this Y- Inst Trans251.92% Short Ratio0.07 Perf Half Y6.54%
Book/sh8.54 P/B0.37 EPS next Y- ROA-66.62% Short Interest0.03M Perf Year-55.59%
Cash/sh20.35 P/C0.16 EPS next 5Y- ROE-83.50% 52W Range2.41 - 15.70 Perf YTD-33.33%
Dividend Est.- P/FCF- EPS past 5Y53.87% ROI-117.91% 52W High-79.87% Beta0.69
Dividend TTM- Quick Ratio2.44 Sales past 5Y58.16% Gross Margin17.97% 52W Low30.90% ATR (14)0.36
Dividend Ex-Date- Current Ratio3.05 EPS Y/Y TTM56.72% Oper. Margin-166.16% RSI (14)36.24 Volatility4.76% 12.25%
Employees13 Debt/Eq0.15 Sales Y/Y TTM-11.94% Profit Margin-163.77% Recom3.00 Target Price400.00
Option/ShortNo / Yes LT Debt/Eq0.09 EPS Q/Q1.71% Payout- Rel Volume0.07 Prev Close3.10
Sales Surprise- EPS Surprise- Sales Q/Q-10.36% EarningsFeb 12 BMO Avg Volume490.41K Price3.16
SMA20-11.43% SMA50-26.08% SMA200-35.59% Trades Volume34,131 Change1.94%
Feb-12-25 06:54PM
Feb-03-25 07:30AM
Jan-22-25 07:30AM
Jan-21-25 07:30AM
Dec-18-24 08:00PM
04:56PM Loading…
Dec-17-24 04:56PM
Nov-19-24 07:30AM
Nov-14-24 04:45PM
Nov-08-24 04:44PM
Nov-05-24 08:30AM
Oct-28-24 07:30AM
Oct-24-24 08:00AM
Oct-22-24 08:00AM
Sep-30-24 08:00AM
Sep-20-24 04:30PM
07:30AM Loading…
Aug-21-24 07:30AM
Aug-20-24 07:30AM
Jul-30-24 08:00AM
Jun-28-24 06:00AM
Jun-12-24 07:00AM
Jun-11-24 07:00AM
Jun-10-24 05:18PM
Jun-06-24 07:38AM
May-14-24 10:53PM
08:30AM
Apr-18-24 08:00AM
Apr-16-24 08:00AM
Apr-04-24 08:00AM
Mar-20-24 08:30AM
Feb-13-24 05:41PM
08:00AM Loading…
Feb-09-24 08:00AM
Jan-18-24 04:41PM
Jan-16-24 08:00AM
Dec-19-23 06:03PM
Nov-29-23 08:00AM
Nov-14-23 08:04AM
Nov-02-23 08:00AM
Oct-26-23 07:15PM
Oct-25-23 09:00AM
Oct-24-23 04:38PM
07:30AM
Sep-29-23 01:21PM
Sep-22-23 06:15PM
Sep-07-23 08:30AM
Jul-21-23 07:30AM
Jul-20-23 07:30AM
Jun-22-23 02:28PM
07:30AM
Jun-01-23 07:30AM
May-24-23 06:51PM
May-18-23 05:00PM
May-15-23 12:33PM
Mar-28-23 07:30AM
Mar-13-23 07:30AM
Mar-10-23 08:35AM
Mar-07-23 08:35AM
07:00AM
Mar-06-23 06:00PM
Feb-17-23 05:00PM
Feb-09-23 09:41PM
Jan-10-23 07:30AM
Dec-15-22 06:17PM
Dec-12-22 06:47PM
Nov-23-22 12:18PM
Nov-21-22 05:00PM
Nov-18-22 08:00AM
Nov-17-22 10:32AM
07:30AM
Nov-16-22 12:13PM
07:00AM
Nov-11-22 06:51PM
Nov-10-22 07:30AM
Oct-26-22 07:30AM
Oct-24-22 10:13AM
Sep-23-22 12:29PM
Sep-19-22 06:00PM
Sep-13-22 05:12PM
Sep-09-22 05:00PM
Sep-08-22 02:08PM
Aug-23-22 05:00PM
Aug-09-22 07:30AM
Jul-25-22 07:30AM
Jul-18-22 07:30AM
Jul-12-22 11:33PM
Jun-14-22 07:30AM
Jun-09-22 07:30AM
Jun-06-22 06:49PM
Jun-02-22 08:00AM
May-13-22 08:45AM
07:30AM
May-05-22 07:30AM
May-03-22 12:00PM
Apr-28-22 07:30AM
Apr-21-22 07:30AM
Apr-19-22 07:30AM
Mar-17-22 07:30AM
Mar-08-22 07:30AM
Feb-16-22 07:30AM
Feb-15-22 07:30AM
Feb-14-22 08:45PM
InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. The InMed Pharma segment is organized around the research and development of small molecule pharmaceuticals drug candidates. The BayMedica segment focuses on the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MANCINI ALEXANDRA DIANE JANETConsultantJul 31 '24Sale0.18240420Aug 02 04:02 PM
HULL ANDREWDirectorFeb 21 '24Buy0.3937,50014,62538,258Feb 22 01:38 PM
ADAMS ERIC APresident & CEOFeb 20 '24Buy0.3641,60014,92243,959Feb 21 02:58 PM